Jaringan Indonesia Positif

Jaringan Indonesia Positif (JIP) is a non-profit organization based in Jakarta, Indonesia, registered in the U.S. government's System for Award Management (SAM.gov) with a registration valid through October 2025. The organization specializes in HIV/AIDS-related services and community health initiatives, focusing on strengthening partnerships between civil society organizations, district health offices, and health facilities to improve HIV service quality. Although specific details about its founding or complete organizational history are not provided, the entity appears to be a key implementer of HIV/AIDS programs in Indonesia, working closely with U.S. government health initiatives.

JIP has been a prime and sub-recipient of federal grant awards from the U.S. Agency for International Development (USAID), specifically through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program. Its most significant recent award is a $1,517,439 five-year Cooperative Agreement starting in September 2024, aimed at strengthening community perspectives in HIV services. The organization has worked with prime grantee Family Health International on sub-awards focused on comprehensive HIV prevention, care, and treatment services in Jakarta and Greater Jakarta. The grant awards involve critical objectives such as influencing policy, advocating for improved data collection and reporting, and expanding community-led monitoring of HIV services. Through these grants, JIP provides technical assistance, service delivery support, policy advocacy, and community engagement to help achieve HIV epidemic control in Indonesia, collaborating closely with local health offices and international health organizations.